Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes
Novo Nordisk announced today that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults.
http://digg.com/u1LMxz
No comments:
Post a Comment